1-Hydroxybenzotriazole → 3-[2-(2-Methylsulfanyl-pyrimidine-4-carbonyl)-pyrazolidin-1-yl]-3-oxo-propionic acid ethyl ester

HRID 1455249

Reaction equation

HRID 1455249 reaction equation
[CH2:1]([O:3][C:4](=[O:13])[CH2:5][C:6](=[O:12])[N:7]1[CH2:11][CH2:10][CH2:9][NH:8]1)[CH3:2].[CH3:14][S:15][C:16]1[N:21]=[C:20]([C:22](O)=[O:23])[CH:19]=[CH:18][N:17]=1.ON1C2C=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC.C([O-])(O)=O.[Na+]>CN(C=O)C>[CH2:1]([O:3][C:4](=[O:13])[CH2:5][C:6]([N:7]1[CH2:11][CH2:10][CH2:9][N:8]1[C:22]([C:20]1[CH:19]=[CH:18][N:17]=[C:16]([S:15][CH3:14])[N:21]=1)=[O:23])=[O:12])[CH3:2]

Participants

7

Procedure

To a solution of the 3-oxo-3-pyrazolidin-1-yl propionic acid ethyl ester, 11, (8.8 g, 47.7 mmol) in DMF (165 mL) is added 2-methylsulfanyl-pyrimidine-4-carboxylic acid (8.5 g, 50.1 mmol), followed by 1-hydroxybenzotriazole (12.9 g, 95.5 mmol) and then 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (11.0 g, 57.3 mmol). The reaction mixture is stirred at room temperature for 22 hours then poured into aqueous saturated NaHCO3. The aqueous phase is extracted three times with EtOAc and the combined organic phases are dried (MgSO4), filtered and concentrated in vacuo to afford 10.5 g of the desired compound which is used without further purification.

Workup

  1. extractionThe aqueous phase is extracted three times with EtOAc
  2. dry with materialthe combined organic phases are dried (MgSO4)
  3. filtrationfiltered
  4. concentrationconcentrated in vacuo

Sources & evidence

ORD record
ord-1de3e9816c604e9bb1c03cc575f2b70e
Source dataset
uspto-grants-2009_01
Patent number
US07482356B2

Linked notes

Loading…